AR088691A1 - Derivados antibioticos de 2-oxo-oxazolidin-3,5-diilo - Google Patents
Derivados antibioticos de 2-oxo-oxazolidin-3,5-diiloInfo
- Publication number
- AR088691A1 AR088691A1 ARP120104192A ARP120104192A AR088691A1 AR 088691 A1 AR088691 A1 AR 088691A1 AR P120104192 A ARP120104192 A AR P120104192A AR P120104192 A ARP120104192 A AR P120104192A AR 088691 A1 AR088691 A1 AR 088691A1
- Authority
- AR
- Argentina
- Prior art keywords
- diilo
- oxazolidin
- oxo
- antibiotic derivatives
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Detergent Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Reivindicación 1: Un compuesto de fórmula (1) en donde R¹ᵃ representa H o carboxi y R¹ᵇ representa H, o R¹ y R¹ᵇ representan en conjunto el grupo *-C(O)-NH-S-# o el grupo *-C(OH)=N-S-# en donde * representa el punto de unión de R¹ᵃ y # representa el punto de unión de R¹ᵇ; R² representa H, alquilo C₁₋₃, hidroxi-alquilo C₁₋₃, bencilo o cicloalquilo C₃₋₅; R³ representa H o halógeno; U representa N o CR⁴; en donde R⁴ es H o alcoxi C₁₋₃; A representa CH, B representa NH, m representa 1 ó 2 y n representa 1 ó 2; o A representa N, B está ausente, m representa 2 y n representa 2; Y representa CH o N; y Q representa O ó S; o una sal de dicho compuesto.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2011054968 | 2011-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR088691A1 true AR088691A1 (es) | 2014-06-25 |
Family
ID=47258051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120104192A AR088691A1 (es) | 2011-11-08 | 2012-11-07 | Derivados antibioticos de 2-oxo-oxazolidin-3,5-diilo |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9079922B2 (es) |
| EP (1) | EP2776431B1 (es) |
| JP (1) | JP6030146B2 (es) |
| KR (1) | KR20140096337A (es) |
| AR (1) | AR088691A1 (es) |
| AU (1) | AU2012335207B2 (es) |
| BR (1) | BR112014011064A8 (es) |
| CA (1) | CA2854264A1 (es) |
| CL (1) | CL2014001154A1 (es) |
| ES (1) | ES2581056T3 (es) |
| HK (1) | HK1202288A1 (es) |
| IL (1) | IL232463A0 (es) |
| IN (1) | IN2014CN04126A (es) |
| MX (1) | MX344529B (es) |
| PH (1) | PH12014500831A1 (es) |
| PL (1) | PL2776431T3 (es) |
| RU (1) | RU2616609C2 (es) |
| SG (1) | SG11201401710PA (es) |
| TW (1) | TWI594996B (es) |
| WO (1) | WO2013068948A1 (es) |
| ZA (1) | ZA201404176B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI415853B (zh) | 2008-10-07 | 2013-11-21 | Actelion Pharmaceuticals Ltd | 三環唑啶酮抗生素化合物 |
| BR112015026261A8 (pt) | 2013-04-16 | 2017-12-26 | Actelion Pharmaceuticals Ltd | Derivados biaromáticos antibacterianos |
| AR096135A1 (es) | 2013-05-02 | 2015-12-09 | Actelion Pharmaceuticals Ltd | Derivados de la quinolona |
| AR102256A1 (es) | 2014-10-15 | 2017-02-15 | Actelion Pharmaceuticals Ltd | Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi |
| MA41168A (fr) | 2014-12-17 | 2017-10-24 | Acraf | Nouveaux composés antibactériens |
| MA41169A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
| SG11201806166WA (en) * | 2016-02-08 | 2018-08-30 | Redx Pharma Plc | Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds |
| WO2017137743A1 (en) * | 2016-02-08 | 2017-08-17 | Redx Pharma Plc | Antibacterial compounds |
| GB201602235D0 (en) * | 2016-02-08 | 2016-03-23 | Redx Pharma Plc | Antibacterial compounds |
| SMT202000335T1 (it) | 2016-06-08 | 2020-07-08 | Acraf | Nuovi composti antibatterici |
| TW201833120A (zh) | 2017-02-17 | 2018-09-16 | 瑞士商愛杜西亞製藥有限公司 | 芳基噁唑啶酮抗生素化合物 |
| US10912780B2 (en) | 2017-06-08 | 2021-02-09 | Bugworks Research, Inc. | Heterocyclic compounds useful as anti-bacterial agents and method for production thereof |
| EP3717490B1 (en) | 2017-11-29 | 2023-05-24 | Bugworks Research, Inc. | Anti-bacterial heterocyclic compounds and their synthesis |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3149104A (en) | 1961-01-03 | 1964-09-15 | Sterling Drug Inc | 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters |
| HU168497B (es) | 1972-12-18 | 1976-05-28 | ||
| SE444566B (sv) | 1977-09-20 | 1986-04-21 | Bellon Labor Sa Roger | 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav |
| GB1598915A (en) | 1977-09-20 | 1981-09-23 | Bellon Labor Sa Roger | 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them |
| CS274601B2 (en) | 1983-07-27 | 1991-09-15 | Dainippon Pharmaceutical Co | Method of 1,8-naphthyridine derivative production |
| JPS62205060A (ja) | 1986-03-04 | 1987-09-09 | Kyorin Pharmaceut Co Ltd | ８位置換キノロンカルボン酸誘導体 |
| FI871419A (fi) | 1986-03-31 | 1987-10-01 | Sankyo Co | Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning. |
| JP2631854B2 (ja) | 1987-12-23 | 1997-07-16 | 藤本製薬株式会社 | 新規な１，８−ナフチリジン誘導体 |
| DE4301246A1 (de) | 1993-01-19 | 1994-07-21 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäurederivate |
| EP1553093A1 (en) | 2002-06-28 | 2005-07-13 | Kaneka Corporation | Process for preparation of optically active 1-substituted amino-2,3-epoxypropanes, intermediates for the synthesis thereof and process for preparation of the intermediates |
| BRPI0409955A (pt) * | 2003-04-30 | 2006-04-25 | Morphochem Ag Komb Chemie | uso de antibióticos hìbridos de oxazolidinona - quinolina para o tratamento de antrax e outras infecções |
| ATE401326T1 (de) * | 2003-12-18 | 2008-08-15 | Morphochem Ag Komb Chemie | Oxazolidinon-chinolon hybrid antibiotika |
| CA2572442A1 (fr) * | 2004-07-30 | 2006-03-09 | Palumed S.A. | Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien |
| CA2578081A1 (en) | 2004-09-01 | 2006-03-09 | Ubitrak Inc. | System for gaming chip identification and counting |
| US20090156577A1 (en) | 2004-09-09 | 2009-06-18 | Benjamin Davis | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| JP2009532504A (ja) | 2006-04-06 | 2009-09-10 | グラクソ グループ リミテッド | 抗菌薬 |
| KR101118402B1 (ko) * | 2006-11-10 | 2012-03-07 | 액테리온 파마슈티칼 리미티드 | 5-하이드록시메틸-옥사졸리딘-2-원 유도체 |
| CL2008001002A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| CL2008001003A1 (es) * | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| JP5323088B2 (ja) * | 2007-12-18 | 2013-10-23 | アクテリオン ファーマシューティカルズ リミテッド | ５−アミノシクリルメチル−オキサゾリジン−２−オン誘導体 |
| MX2010008921A (es) * | 2008-02-22 | 2010-09-07 | Actelion Pharmaceuticals Ltd | Derivados de oxazolidinona. |
| TWI415853B (zh) | 2008-10-07 | 2013-11-21 | Actelion Pharmaceuticals Ltd | 三環唑啶酮抗生素化合物 |
| US20110195949A1 (en) * | 2008-10-10 | 2011-08-11 | Actelion Pharmaceuticals Ltd. | 2-benzothiophenyl- and 2-naphthyl-oxazolidinones and their azaisostere analogues as antibacterial agents |
| JP5490809B2 (ja) * | 2008-10-10 | 2014-05-14 | アクテリオン ファーマシューティカルズ リミテッド | オキサゾリジニル抗生物質 |
| TW201121965A (en) | 2009-09-28 | 2011-07-01 | Lg Life Sciences Ltd | Use of a quinolone derivative containing 7-(4-aminomethyl-3-oxime)pyrrolidine group that is capable of inducing granulocyte colony stimulating factor for treatment of neutropenia and recovery of hematopoiesis |
| CN101792443A (zh) | 2010-03-09 | 2010-08-04 | 北京欧凯纳斯科技有限公司 | 氟代喹诺酮衍生物及其制备方法和用途 |
-
2012
- 2012-11-07 AR ARP120104192A patent/AR088691A1/es unknown
- 2012-11-07 IN IN4126CHN2014 patent/IN2014CN04126A/en unknown
- 2012-11-07 ES ES12791863.9T patent/ES2581056T3/es active Active
- 2012-11-07 EP EP12791863.9A patent/EP2776431B1/en not_active Not-in-force
- 2012-11-07 AU AU2012335207A patent/AU2012335207B2/en not_active Ceased
- 2012-11-07 US US14/356,896 patent/US9079922B2/en not_active Expired - Fee Related
- 2012-11-07 BR BR112014011064A patent/BR112014011064A8/pt not_active Application Discontinuation
- 2012-11-07 PH PH1/2014/500831A patent/PH12014500831A1/en unknown
- 2012-11-07 TW TW101141423A patent/TWI594996B/zh not_active IP Right Cessation
- 2012-11-07 PL PL12791863.9T patent/PL2776431T3/pl unknown
- 2012-11-07 CA CA2854264A patent/CA2854264A1/en not_active Abandoned
- 2012-11-07 KR KR1020147014957A patent/KR20140096337A/ko active IP Right Grant
- 2012-11-07 WO PCT/IB2012/056236 patent/WO2013068948A1/en active Application Filing
- 2012-11-07 JP JP2014540612A patent/JP6030146B2/ja not_active Expired - Fee Related
- 2012-11-07 RU RU2014123109A patent/RU2616609C2/ru not_active IP Right Cessation
- 2012-11-07 MX MX2014005637A patent/MX344529B/es active IP Right Grant
- 2012-11-07 SG SG11201401710PA patent/SG11201401710PA/en unknown
-
2014
- 2014-04-30 CL CL2014001154A patent/CL2014001154A1/es unknown
- 2014-05-05 IL IL232463A patent/IL232463A0/en unknown
- 2014-06-06 ZA ZA2014/04176A patent/ZA201404176B/en unknown
-
2015
- 2015-03-16 HK HK15102622.5A patent/HK1202288A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2014123109A (ru) | 2015-12-20 |
| EP2776431B1 (en) | 2016-05-04 |
| SG11201401710PA (en) | 2014-09-26 |
| AU2012335207B2 (en) | 2017-05-25 |
| EP2776431A1 (en) | 2014-09-17 |
| BR112014011064A8 (pt) | 2017-12-26 |
| CN103917539A (zh) | 2014-07-09 |
| JP6030146B2 (ja) | 2016-11-24 |
| MX2014005637A (es) | 2014-06-23 |
| ZA201404176B (en) | 2016-05-25 |
| PH12014500831A1 (en) | 2019-08-07 |
| IN2014CN04126A (es) | 2015-07-10 |
| CA2854264A1 (en) | 2013-05-16 |
| IL232463A0 (en) | 2014-06-30 |
| MX344529B (es) | 2016-12-19 |
| KR20140096337A (ko) | 2014-08-05 |
| TW201326166A (zh) | 2013-07-01 |
| AU2012335207A1 (en) | 2014-07-03 |
| US20150051188A1 (en) | 2015-02-19 |
| HK1202288A1 (en) | 2015-09-25 |
| PL2776431T3 (pl) | 2016-11-30 |
| CL2014001154A1 (es) | 2014-09-12 |
| WO2013068948A1 (en) | 2013-05-16 |
| JP2014532754A (ja) | 2014-12-08 |
| RU2616609C2 (ru) | 2017-04-18 |
| TWI594996B (zh) | 2017-08-11 |
| US9079922B2 (en) | 2015-07-14 |
| BR112014011064A2 (pt) | 2017-06-13 |
| ES2581056T3 (es) | 2016-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR088691A1 (es) | Derivados antibioticos de 2-oxo-oxazolidin-3,5-diilo | |
| EA201700230A1 (ru) | Определенные аминопиридины, композиции на их основе и способы их применения | |
| AR101815A1 (es) | Compuestos y composiciones como inhibidores de quinasa | |
| EA201490518A1 (ru) | Пирролбензодиазепины | |
| RS54873B1 (sr) | Policiklična-karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba | |
| TN2015000175A1 (en) | Heteroaryl substituted pyridyl compounds useful as kinase modulators | |
| RS54730B1 (sr) | Inhibitori beta sekretaze | |
| EA201201377A1 (ru) | Определенные аминопиридазины, композиции на их основе и способы их использования | |
| EA201591486A1 (ru) | Соединения имидазопиридина | |
| CY1119220T1 (el) | Μονοκυκλικο παραγωγο πυριδινης | |
| RS53301B (en) | TIOACETATE COMPOUNDS, COMPOSITIONS AND USE PROCEDURES | |
| RS54386B1 (en) | ANTIVIRAL UNITS | |
| AR095523A1 (es) | Derivados piridin-4-ilo | |
| EA201590979A1 (ru) | Способы и промежуточные химические соединения для получения фармацевтических средств | |
| UA114325C2 (uk) | Феноксіетилпіперидинові сполуки | |
| AR089623A1 (es) | Inhibidores de iap | |
| RU2012148909A (ru) | Новый синтез соединений тиазолидиндиона | |
| MY160882A (en) | Biocidal composition and method | |
| RS54488B1 (en) | NALOXOL-POLYETHYLENE GLYCOL CRYSTAL CONJUGATE | |
| EA201690894A1 (ru) | Феноксиэтилы | |
| JO3318B1 (ar) | مثبطات bace | |
| EA201491852A1 (ru) | Новые пиразольные соединения | |
| BR112014030720A2 (pt) | inibidores de fbxo3 | |
| MX2017005423A (es) | Inhibidores de histona desacetilasa y sus usos en terapia. | |
| CY1114020T1 (el) | 3-αμινοκυκλοπεντανοκαρβοξαμιδια ως διαμορφωτες υποδοχεα χημοκινης |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |